NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
NAVCO Pharmaceuticals Inc. has partnered with SOF Marketing on a $300,000 CAD initiative aimed at enhancing investor relations through a comprehensive online marketing strategy. The campaign, running until October 12, 2024, includes rebranding, social media marketing, and targeted AdWords advertising. NAVCO specializes in nanotechnology for developing innovative products to combat various pathogens, serving markets in human health, household products, and veterinary care.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.